MitraClip™ Guide delivery achieved in under 7.5 minutes1 TORONTO, Dec. 1, 2020 /PRNewswire/ – A recent publication demonstrated procedural efficiency for MitraClip™ transcatheter mitral valve repair (TMVR) with use of the VersaCross® RF Transseptal Solution, reporting guide delivery from femoral access in under 7.5 minutes1. The VersaCross solution features a single radiofrequency (RF)-tipped wire used to introduce the transseptal sheath into the superior vena cava (SVC), […]
Other News
Zimmer Biomet Completes Acquisition of A&E Medical Corporation
Deal Adds Innovative Solutions and Establishes High-Growth Market Leadership for Zimmer Biomet WARSAW, Ind., Dec. 1, 2020 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the company has completed the acquisition of A&E Medical Corporation, a Vance Street Capital Portfolio Company, for $150 […]
VivaLNK Appoints Jennifer Esposito to Board of Directors
Veteran in Healthcare industry to advise VivaLNK’s executive team and assist in its growth in the Digital Health space CAMPBELL, Calif., Dec. 1, 2020 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions known for its unique medical wearable sensor platform and vitals data service, announces today that Jennifer Esposito joins its Board of […]
Ionis announces AstraZeneca’s initiation of the Phase 2b clinical study of its antisense medicine targeting PCSK9 to lower LDL-cholesterol
Phase 1 results for ION449 (AZD8233) demonstrate best-in-class potential, showing potent, dose-dependent PCSK9 reductions of >90% with favorable safety profile CARLSBAD, Calif., Nov. 30, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that the biopharmaceutical company AstraZeneca has initiated a Phase 2b clinical trial of ION449 (AZD8233), an investigational antisense medicine designed to reduce blood cholesterol levels […]
Momentum Continues for Visage at RSNA 2020
Visage 7 Live Connect enables simple radiologist collaboration with referrers SAN DIEGO, Nov. 30, 2020 /PRNewswire/ — Visage Imaging, Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will be showcasing the latest version of the Visage® 7 Enterprise Imaging Platform, featuring the introduction of Visage 7 Live Connect (as a works-in-progress), […]
Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business
MARLBOROUGH, Mass., Dec. 1, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, to sell its BTG Specialty Pharmaceuticals business for $800 million in cash. SERB, backed by private equity firm […]
Shapa Health Leverages Core Behavioral Economics Technology and Platform to Tackle Hypertension and White Coat Syndrome
CUPERTINO, Calif., Dec. 1, 2020 /PRNewswire/ — Shapa, a leading Silicon Valley based health IT technology company, announced today their entry into the cardiovascular health management market. Previous studies from Shapa, as well as recent user data, have proven that over 79.8% of users continue to weigh themselves daily and lose or maintain […]
BioCardia Reports Published Study Showing Helix Biotherapeutic Delivery System Used in CardiAMP Phase III Heart Failure Trial Has Fewest Adverse Events Among Competitive Delivery Systems
SAN CARLOS, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA] today announced that the Company’s proprietary Helix Biotherapeutic Delivery System (the Helix System) demonstrated the best safety profile among clinical transendocardial catheter injection systems used for cardiac cell therapy delivery in an in-press corrected proof published in the journal, Cardiovascular […]
Cytokinetics Announces Additional Results From GALACTIC-HF to be Presented at the 17th Global Cardiovascular Clinical Trialists Forum
Data from Supplemental Analyses to be Shared at Clinical Trials Think Tank Meeting SOUTH SAN FRANCISCO, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced additional results from GALACTIC-HF (Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in Heart Failure), the Phase 3 event driven cardiovascular outcomes clinical trial of omecamtiv mecarbil, will be presented at […]
Biotricity Prepares 510(k) FDA Filing for Biotres
Required lab testing complete for Biotres a novel holter patch product REDWOOD CITY, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed required lab testing and is completing its 510(k) FDA filing for its latest potential product […]



